Àngels López 
Application Deadline: 30/04/2017
Ref: PD-JR
The Biosensors for bioengineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral Researcher in order to work in the project Diabetes Approach by Multi-Organ-on-a-Chip (DAMOC).This position will be funded by the “ERC Starting Grant” from the European Research Council (ERC).
Premi Nacional de Recerca winners Samuel Sanchez and ICFO’s Lluís Torner appeared on El Punt Avui’s L’Illa de Robinson programme on Wednesday, after the awards ceremony on Tuesday night. It’s just one example of the huge amount of press coverage there’s been about the awards.
Yesterday IBEC group leader and ICREA research professor Samuel Sánchez was one of the five honorees at the ceremony of the Premis Nacionals de Recerca 2016 of the Fundació Catalana per a la Recerca i la Innovació (FCRI).Samuel received his Young Talent award from president of the Generalitat Carles Puigdemont, Minister for Business and Enterprise Jordi Baiget, actress Silvia Bel, and FCRI president Antoni Esteve at the Teatre Nacional de Catalunya.
This week IBEC is attending BIO-EUROPE SPRING, the premier partnering conference that brings together the “who’s who” from biotech, pharma and finance in Europe.Taking place at the CCIB convention centre today, tomorrow and Wednesday, BIO-EUROPE SPRING will welcome more than 2400 attendees from 1400 companies from more than 45 countries.
IBEC’s Technology Transfer head Xavier Rubies will be there for the three days presenting the institute’s portfolio of patents and technologies to look for partners, attending company presentations and networking.
Some IBEC research published in PlosOne offers a step towards better screening of patients with asthma and other sufferers of obstructive pulmonary diseases. The new integrated approach to continuous adventitious respiratory sound (CAS) analysis, developed by Raimon Jané’s Biomedical Signal Processing and Interpretation group within the framework of IBEC’s Joint Research Unit with the Institut d’Investigació Hospital Germans Trias i Pujol (IGTP), improves assessment in the clinic.
IBEC researchers have laid the groundwork for faster advances in 3D bioprinting for regenerative medicine by creating a system of ink and matrices that offers a solid basis for tissue regeneration.Due to their high water content, hydrogels are highly attractive biomaterials for 3D printing as efficient ‘surrogates’ for the extracellular matrix, onto which cells can be cultured. However, while they are relatively easy to produce using a method called extrusion printing, their stability and structural integrity can weaken when they’re in contact with biological fluids or extracellular matrices.
Application Deadline: 30/03/2017
Ref: TC-JR
The Biosensors for bioengineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Laboratory Technician .This position will be funded by the “ERC Starting Grant” from the European Research Council (ERC).
The Spanish Platform for Nanomedicine (NanoMedSpain), led by IBEC Director Josep Samitier, is participating once again in the Annual Conference of Technological Platforms of Biomedical Research in Madrid this week.This year, NanoMed Spain has invited Pier Maria Fornasari, Director of Complex Structures at the Instituto Ortopedico Rizzoli di Bologna. He will represent the ‘Biofabrication for Regenerative Medicine’ joint proposal sent to the European Commission in response to their call for new FET Flagship initiatives for the next work program.
This week IBEC is taking part in the Youth Mobile Festival (YOMO) of the Mobile World Congress, the world’s largest gathering for the mobile industry, with an interactive stand about bioengineering for cardiac regeneration.Members of the Biomaterials for Regenerative Therapies group, Soledad Pérez, Jesús Ordoño and Gerard Rubí, will explain the research carried out to regenerate the heart using biodegradable and bioactive materials. With the aid of a 3D pen, attendees will be able to replicate one of the techniques that are used for research in this area.
Researchers at IBEC have identified a potential way to slow down the neurodegenerative progression of Parkinson’s disease. They focused their work on the cellular prion protein (PrPc), a specialized molecule located in the membranes of neurons that’s involved in a number of functions such as cell cycle control and neurotransmission.